NeuroMetrix, Inc. (NURO)
USD 4.47
(1.08%)
USD 4.47
(1.08%)
| Year | EBITDA | EBITDA Growth |
|---|---|---|
| 2023 | -7.09 Million USD | -49.64% |
| 2022 | -4.69 Million USD | -107.55% |
| 2021 | -2.2 Million USD | -9.06% |
| 2020 | -2 Million USD | 81.84% |
| 2019 | -8.79 Million USD | 6.16% |
| 2018 | -12.12 Million USD | 7.52% |
| 2017 | -12.82 Million USD | 14.16% |
| 2016 | -14.95 Million USD | 10.81% |
| 2015 | -13.05 Million USD | -77.7% |
| 2014 | -8.62 Million USD | -45.97% |
| 2013 | -7.2 Million USD | 33.22% |
| 2012 | -9.72 Million USD | -4.11% |
| 2011 | -9.6 Million USD | 42.65% |
| 2010 | -16.48 Million USD | -1281.1% |
| 2009 | -11.33 Million USD | -123.12% |
| 2008 | -19.53 Million USD | 153.93% |
| 2007 | -7.95 Million USD | -384.44% |
| 2006 | 4.84 Million USD | 300.78% |
| 2005 | 1.25 Million USD | 125.69% |
| 2004 | -3.11 Million USD | 0.31% |
| 2003 | -3.33 Million USD | 26.97% |
| 2002 | -4.57 Million USD | -777.84% |
| 2001 | -520.86 Thousand USD | 0.0% |
| Year | EBITDA | EBITDA Growth |
|---|---|---|
| 2024 Q2 | -1.73 Million USD | 42.2% |
| 2024 Q3 | -1.74 Million USD | 3.14% |
| 2024 Q1 | -3.22 Million USD | -63.98% |
| 2023 Q1 | -1.71 Million USD | -99.67% |
| 2023 Q2 | -1.62 Million USD | 5.06% |
| 2023 Q3 | -1.96 Million USD | -20.79% |
| 2023 FY | - USD | -49.64% |
| 2023 Q4 | -1.83 Million USD | 6.56% |
| 2022 Q4 | -856.46 Thousand USD | 49.62% |
| 2022 FY | - USD | -107.55% |
| 2022 Q1 | -949.11 Thousand USD | 5.51% |
| 2022 Q2 | -1.19 Million USD | -26.11% |
| 2022 Q3 | -1.7 Million USD | -42.04% |
| 2021 Q3 | -663.88 Thousand USD | -39.87% |
| 2021 Q4 | -1 Million USD | -51.3% |
| 2021 Q1 | -38.01 Thousand USD | 88.35% |
| 2021 Q2 | -474.63 Thousand USD | -1148.61% |
| 2021 FY | - USD | -9.06% |
| 2020 Q3 | -257.88 Thousand USD | 68.96% |
| 2020 Q4 | -326.15 Thousand USD | -26.47% |
| 2020 FY | - USD | 81.84% |
| 2020 Q2 | -830.81 Thousand USD | -30.95% |
| 2020 Q1 | -634.46 Thousand USD | 61.76% |
| 2019 Q2 | -4.76 Million USD | -28.68% |
| 2019 Q3 | -1.41 Million USD | 70.35% |
| 2019 Q4 | -1.65 Million USD | -17.48% |
| 2019 FY | - USD | 6.16% |
| 2019 Q1 | -3.7 Million USD | -31.19% |
| 2018 FY | - USD | 7.52% |
| 2018 Q4 | -2.82 Million USD | -6.16% |
| 2018 Q3 | -2.65 Million USD | 14.32% |
| 2018 Q2 | -3.1 Million USD | 13.86% |
| 2018 Q1 | -3.6 Million USD | -24.85% |
| 2017 Q3 | -3.51 Million USD | -0.32% |
| 2017 Q2 | -3.5 Million USD | -5.16% |
| 2017 Q1 | -3.33 Million USD | -14.37% |
| 2017 FY | - USD | 14.16% |
| 2017 Q4 | -2.88 Million USD | 17.91% |
| 2016 FY | - USD | 10.81% |
| 2016 Q2 | -4.19 Million USD | 2.3% |
| 2016 Q3 | -3.96 Million USD | 5.49% |
| 2016 Q4 | -2.91 Million USD | 26.5% |
| 2016 Q1 | -4.29 Million USD | -9.16% |
| 2015 Q2 | -5.47 Million USD | -23.18% |
| 2015 Q1 | -4.44 Million USD | -133.72% |
| 2015 Q4 | -3.93 Million USD | -14.14% |
| 2015 FY | - USD | -77.7% |
| 2015 Q3 | -3.44 Million USD | 37.1% |
| 2014 Q3 | -2.5 Million USD | 17.36% |
| 2014 Q4 | -1.9 Million USD | 24.19% |
| 2014 FY | - USD | -45.97% |
| 2014 Q1 | -2.21 Million USD | -333.63% |
| 2014 Q2 | -3.03 Million USD | -36.75% |
| 2013 Q2 | -2.9 Million USD | -31.28% |
| 2013 Q1 | -2.21 Million USD | -18.05% |
| 2013 Q4 | 950.14 Thousand USD | 138.29% |
| 2013 FY | - USD | 33.22% |
| 2013 Q3 | -2.48 Million USD | 14.63% |
| 2012 Q4 | -1.87 Million USD | 24.82% |
| 2012 Q1 | -2.68 Million USD | -14.63% |
| 2012 FY | - USD | -4.11% |
| 2012 Q2 | -2.77 Million USD | -3.36% |
| 2012 Q3 | -2.49 Million USD | 10.14% |
| 2011 FY | - USD | 42.65% |
| 2011 Q1 | -2.58 Million USD | 40.25% |
| 2011 Q3 | -2.34 Million USD | 0.15% |
| 2011 Q4 | -2.34 Million USD | 0.08% |
| 2011 Q2 | -2.34 Million USD | 9.3% |
| 2010 FY | - USD | -1281.1% |
| 2010 Q4 | -4.33 Million USD | -27.11% |
| 2010 Q3 | -3.4 Million USD | 22.41% |
| 2010 Q2 | -4.39 Million USD | 6.54% |
| 2010 Q1 | -4.7 Million USD | -18.32% |
| 2009 Q3 | 5.61 Million USD | 427.25% |
| 2009 FY | - USD | -123.12% |
| 2009 Q4 | -3.97 Million USD | -170.83% |
| 2009 Q1 | -1.13 Million USD | -108.79% |
| 2009 Q2 | -1.71 Million USD | -50.7% |
| 2008 Q2 | -1.9 Million USD | 46.65% |
| 2008 Q1 | -3.57 Million USD | -46.3% |
| 2008 FY | - USD | 153.93% |
| 2008 Q3 | -2.2 Million USD | -15.26% |
| 2008 Q4 | 12.94 Million USD | 688.32% |
| 2007 Q3 | -3.91 Million USD | -138.54% |
| 2007 Q2 | -1.64 Million USD | 5.69% |
| 2007 Q4 | -2.44 Million USD | 37.58% |
| 2007 FY | - USD | -384.44% |
| 2007 Q1 | -1.74 Million USD | -1271.29% |
| 2006 FY | - USD | 300.78% |
| 2006 Q1 | 612.00 USD | -99.92% |
| 2006 Q2 | 1.36 Million USD | 222452.45% |
| 2006 Q4 | -127.01 Thousand USD | -105.8% |
| 2006 Q3 | 2.19 Million USD | 60.91% |
| 2005 Q2 | 92.57 Thousand USD | 113.08% |
| 2005 FY | - USD | 125.69% |
| 2005 Q4 | 737.85 Thousand USD | 0.76% |
| 2005 Q3 | 732.28 Thousand USD | 691.02% |
| 2005 Q1 | -707.56 Thousand USD | 22.72% |
| 2004 FY | - USD | 0.31% |
| 2004 Q4 | -915.64 Thousand USD | -30.64% |
| 2004 Q1 | -590.17 Thousand USD | 90.65% |
| 2004 Q2 | -1.12 Million USD | -90.16% |
| 2004 Q3 | -700.9 Thousand USD | 37.55% |
| 2003 Q2 | 918.74 Thousand USD | 52.31% |
| 2003 FY | - USD | 26.97% |
| 2003 Q4 | -6.31 Million USD | -611.12% |
| 2003 Q1 | 603.19 Thousand USD | 0.0% |
| 2003 Q3 | 1.23 Million USD | 34.38% |
| 2002 FY | - USD | -777.84% |
| 2001 FY | - USD | 0.0% |
| Name | EBITDA | EBITDA Difference |
|---|---|---|
| Accelerate Diagnostics, Inc. | -49.77 Million USD | 85.743% |
| BrainsWay Ltd. | -2.31 Million USD | -207.045% |
| Cerus Corporation | -26.53 Million USD | 73.26% |
| Envoy Medical, Inc. | -18.23 Million USD | 61.093% |
| electroCore, Inc. | -17.76 Million USD | 60.046% |
| Helius Medical Technologies, Inc. | -12.1 Million USD | 41.391% |
| IceCure Medical Ltd | -15.25 Million USD | 53.479% |
| Inogen, Inc. | -45.67 Million USD | 84.466% |
| OrthoPediatrics Corp. | -8.38 Million USD | 15.335% |
| Lucid Diagnostics Inc. | -49.75 Million USD | 85.737% |
| Monogram Orthopaedics, Inc. | -16.85 Million USD | 57.903% |
| MaxCyte, Inc. | -44.12 Million USD | 83.92% |
| NeuroOne Medical Technologies Corporation | -11.75 Million USD | 39.641% |
| Nexalin Technology, Inc. | -5.69 Million USD | -24.662% |
| Orthofix Medical Inc. | -86.98 Million USD | 91.842% |
| PAVmed Inc | -75.74 Million USD | 90.632% |
| Rapid Micro Biosystems, Inc. | -53.75 Million USD | 86.8% |
| RxSight, Inc. | -41.03 Million USD | 82.709% |
| Sight Sciences, Inc. | -49.41 Million USD | 85.64% |
| SI-BONE, Inc. | -34.44 Million USD | 79.4% |
| TELA Bio, Inc. | -40.63 Million USD | 82.537% |
| Treace Medical Concepts, Inc. | -39 Million USD | 81.809% |
| Vivos Therapeutics, Inc. | -16.67 Million USD | 57.446% |
| Acutus Medical, Inc. | -13.48 Million USD | 47.388% |
| Talis Biomedical Corporation | -66.04 Million USD | 89.256% |
| Spectral AI, Inc. | -12.26 Million USD | 42.132% |
| Nano-X Imaging Ltd. | -47.69 Million USD | 85.122% |
| CVRx, Inc. | -38.73 Million USD | 81.679% |
| DIH Holding US, Inc. Warrants | -3.52 Million USD | -101.128% |
| PetVivo Holdings, Inc. | -10.49 Million USD | 32.385% |
| Bioventus Inc. | -23.07 Million USD | 69.242% |
| Venus Concept Inc. | -26.11 Million USD | 72.827% |
| TriSalus Life Sciences, Inc. | -58.29 Million USD | 87.828% |
| LivaNova PLC | 39.01 Million USD | 118.187% |
| 908 Devices Inc. | -34.02 Million USD | 79.145% |
| Alphatec Holdings, Inc. | -110.59 Million USD | 93.584% |
| Nemaura Medical Inc. | -7.28 Million USD | 2.624% |
| NeuroPace, Inc. | -22.83 Million USD | 68.924% |
| LENSAR, Inc. | -8.71 Million USD | 18.57% |
| Apyx Medical Corporation | -18.11 Million USD | 60.823% |
| Cutera, Inc. | -136.56 Million USD | 94.804% |
| STRATA Skin Sciences, Inc. | -3.38 Million USD | -109.935% |
| BioSig Technologies, Inc. | -28.15 Million USD | 74.794% |
| Anika Therapeutics, Inc. | 2.51 Million USD | 382.027% |
| ClearPoint Neuro, Inc. | -20.98 Million USD | 66.193% |
| Integra LifeSciences Holdings Corporation | 383.56 Million USD | 101.85% |
| Axonics, Inc. | 7.77 Million USD | 191.264% |
| Outset Medical, Inc. | -153.78 Million USD | 95.386% |
| IRIDEX Corporation | -7.44 Million USD | 4.729% |
| PROCEPT BioRobotics Corporation | -98.09 Million USD | 92.766% |
| IRadimed Corporation | 20.8 Million USD | 134.113% |
| Tivic Health Systems, Inc. | -8.06 Million USD | 11.984% |
| INVO Bioscience, Inc. | -6.88 Million USD | -3.136% |
| Telesis Bio, Inc. | -40.49 Million USD | 82.476% |
| Viemed Healthcare, Inc. | 36.67 Million USD | 119.347% |
| Varex Imaging Corporation | 67.2 Million USD | 110.559% |
| Quipt Home Medical Corp. | 44.07 Million USD | 116.101% |
| Inspira Technologies Oxy B.H.N. Ltd. | -10.87 Million USD | 34.721% |
| Pulmonx Corporation | -55.09 Million USD | 87.12% |
| Dynatronics Corporation | -976 Thousand USD | -627.024% |
| Modular Medical, Inc. | -17.1 Million USD | 58.511% |
| ReShape Lifesciences Inc. | -14.48 Million USD | 51.013% |
| Semler Scientific, Inc. | 23.58 Million USD | 130.081% |
| InMode Ltd. | 196.28 Million USD | 103.615% |
| Bruker Corporation | 599 Million USD | 101.185% |
| Cytosorbents Corporation | -28.81 Million USD | 75.371% |
| DexCom, Inc. | 916.7 Million USD | 100.774% |
| Align Technology, Inc. | 799.03 Million USD | 100.888% |
| Viveve Medical, Inc. | -20.61 Million USD | 65.583% |
| ZimVie Inc. | 91.07 Million USD | 107.791% |
| Movano Inc. | -29.12 Million USD | 75.637% |
| Cytek Biosciences, Inc. | -4.4 Million USD | -60.976% |
| Nexalin Technology, Inc. | -5.69 Million USD | -24.662% |
| DIH Holdings US, Inc. Class A Common Stock | -3.52 Million USD | -101.128% |
| Tandem Diabetes Care, Inc. | -194.65 Million USD | 96.355% |
| Profound Medical Corp. | -27.12 Million USD | 73.839% |
| Insulet Corporation | 323.6 Million USD | 102.193% |
| enVVeno Medical Corporation | -25.01 Million USD | 71.637% |
| Surmodics, Inc. | 1.18 Million USD | 697.29% |
| iCAD, Inc. | -6.56 Million USD | -8.085% |
| Nuwellis, Inc. | -16.35 Million USD | 56.616% |
| Biotricity, Inc. | -8.82 Million USD | 19.624% |
| iRhythm Technologies, Inc. | -96.86 Million USD | 92.674% |
| Aethlon Medical, Inc. | -11.84 Million USD | 40.115% |
| InspireMD, Inc. | -20.91 Million USD | 66.067% |
| PAVmed Inc. | -75.74 Million USD | 90.632% |
| BIOLASE, Inc. | -15.13 Million USD | 53.129% |
| Beyond Air, Inc. | -59.03 Million USD | 87.98% |
| FONAR Corporation | 28.25 Million USD | 125.117% |
| AxoGen, Inc. | -13.32 Million USD | 46.76% |
| Vivani Medical, Inc. | -26.6 Million USD | 73.332% |
| Tactile Systems Technology, Inc. | 24.54 Million USD | 128.914% |
| Inari Medical, Inc. | 7.11 Million USD | 199.758% |
| UFP Technologies, Inc. | 72.74 Million USD | 109.755% |
| QT Imaging Holdings, Inc. | -3.38 Million USD | -109.576% |
| Heart Test Laboratories, Inc. | -6.15 Million USD | -15.267% |
| Tenon Medical, Inc. | -15.52 Million USD | 54.303% |
| Autonomix Medical, Inc. Common Stock | -15.26 Million USD | 53.519% |
| Co-Diagnostics, Inc. | -41.47 Million USD | 82.892% |
| AdaptHealth Corp. | -171.09 Million USD | 95.853% |
| Sintx Technologies, Inc. | -6.6 Million USD | -7.512% |
| NanoVibronix, Inc. | -3.43 Million USD | -106.574% |
| Quanterix Corporation | -38.08 Million USD | 81.37% |
| Inspira Technologies Oxy B.H.N. Ltd. | -10.87 Million USD | 34.721% |
| Sensus Healthcare, Inc. | 30 Thousand USD | 23752.697% |
| Pacific Biosciences of California, Inc. | -277.28 Million USD | 97.441% |
| TransMedics Group, Inc. | -7.6 Million USD | 6.671% |
| ReWalk Robotics Ltd. | -21.76 Million USD | 67.398% |
| Hyperfine, Inc. | -47.06 Million USD | 84.922% |
| Establishment Labs Holdings Inc. | -58.3 Million USD | 87.83% |
| Biomerica, Inc. | -5.99 Million USD | -18.402% |
| Bone Biologics Corporation | 479.57 Thousand USD | 1579.613% |
| AVITA Medical, Inc. | -39.56 Million USD | 82.067% |
| Bluejay Diagnostics, Inc. | -9.17 Million USD | 22.644% |
| Silk Road Medical, Inc | -45.08 Million USD | 84.26% |